Cargando…
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials
Current therapies for acute kidney injury remain primarily supportive and have failed to reduce morbidity, mortality (>50%), and associated costs. This prompted our studies in which rats with bilateral ischemia/reperfusion-induced acute kidney injury were treated with bone marrow-derived, culture...
Autores principales: | Westenfelder, Christof, Togel, Florian E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089688/ https://www.ncbi.nlm.nih.gov/pubmed/25018910 http://dx.doi.org/10.1038/kisup.2011.24 |
Ejemplares similares
-
Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury
por: Togel, Florian E, et al.
Publicado: (2011) -
Recent advances in the understanding of acute kidney injury
por: Tögel, Florian, et al.
Publicado: (2014) -
Mesenchymal stromal cells: main factor or helper in regenerative medicine?
por: Zander, Axel R, et al.
Publicado: (2011) -
Potential of mesenchymal stem cells in the repair of tubular injury
por: Imberti, Barbara, et al.
Publicado: (2011) -
The definition and detection of acute kidney injury
por: Pickering, John W, et al.
Publicado: (2013)